Thimble Point Acquisition Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- Sponsors
- IPO Size
- $200M
- Underwriters
- Focus
- Software, Technology, Financial Services, Healthcare, Consumer
- SEC Filings
- 1835567
- Public Embarc Page
- https://embarc.com/capital/spac/1835567/THMA/thimble-point-acquisition
- IPO Ticker
- THMA
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and ChairmanElon S. Boms
- Chief Operating Officer and DirectorSteven J. Benson
- Chief Financial OfficerJoseph Iannotta
- DirectorMichael J. Christenson
- DirectorMeghan M. FitzGerald
- DirectorHenry S. Miller
- Anil Aggarwal
- Brian Barth
- Michael K. Simon
- Michael Tessler
- Jarrod Yuster
- Elon Bons(Co-founder, LaunchCapital)
- Michael Simon(Co-founder/Fmr CEO, LogMeIn)
Target Information
Information on the SPAC target for merger.
- Company
- Pear Therapuetics
- Presentation
- Investor Presentation (SEC) on 2021-06-22
- Description
- Pear Therapeutics is "the leader in developing and commercializing prescription digital therapeutics to treat serious disease."